Axon Therapies
PrivateLast Round
Series A
Sep 25, 2025
Total Funding Raised
$32M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Axon Therapies is a medical technology company that develops minimally invasive, implant-free therapies to address the root causes of heart failure.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axon Therapies Comparables
Compare Axon Therapies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alleviant Medical | 83% | |
| Ancora Heart | 81% | |
| Berlin Heals Holding AG | 80% | |
Axon Therapies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 25, 2025 | ||||
| VC Round | Jan 1, 2019 |
Key People
Founding team and executive leadership
Axon Therapies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | VC Round, Series A |
| KOFA Healthcare | Series A |
| Action Potential Venture Capital | VC Round |
| Santé Ventures | Series A |
| Earlybird Venture Capital | Series A |
| Santé Ventures | Series A |
| CD Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 25, 2025
$32M round completed.
- Sep 25, 2025
Zoar Engelman appointed CEO to lead clinical development.
Axon Therapies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Axon Therapies's valuation, stock price, and market status.